MCID: CNT007
MIFTS: 49

Central Nervous System Tuberculosis malady

Categories: Infectious diseases, Neuronal diseases

Aliases & Classifications for Central Nervous System Tuberculosis

About this section

Aliases & Descriptions for Central Nervous System Tuberculosis:

Name: Central Nervous System Tuberculosis 11 13
Intracranial Tuberculoma 11 67
Tuberculosis of Meninges and Central Nervous System 11
Tuberculosis, Central Nervous System 67
 
Tuberculous Abscess of Brain 11
Tuberculoma, Intracranial 38
Tuberculoma of Brain 11

Classifications:



External Ids:

Disease Ontology11 DOID:1638
ICD9CM31 013.2, 013.20
SNOMED-CT61 40769007, 416265003
MeSH38 D016862

Summaries for Central Nervous System Tuberculosis

About this section
Disease Ontology:11 An extrapulmonary tuberculosis that results in formation of tuberculomas located in brain or located in spinal cord.

MalaCards based summary: Central Nervous System Tuberculosis, also known as intracranial tuberculoma, is related to tuberculosis and skull base meningioma, and has symptoms including mass in head or neck An important gene associated with Central Nervous System Tuberculosis is MMP9 (Matrix Metallopeptidase 9), and among its related pathways are Immune response_Oncostatin M signaling via JAK-Stat in human cells and CXCR4-mediated signaling events. Affiliated tissues include brain or, brain and spinal cord, and related mouse phenotypes are neoplasm and cardiovascular system.

Related Diseases for Central Nervous System Tuberculosis

About this section

Diseases related to Central Nervous System Tuberculosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 91)
idRelated DiseaseScoreTop Affiliating Genes
1tuberculosis10.7
2skull base meningioma10.6CD163, CD207
3siderosis10.5CD4, FAS
4diabetic cataract10.4IL1B, MMP9
5penis squamous cell carcinoma10.4MMP9, TIMP1
6adenosquamous bile duct carcinoma10.4CD163, CD207
7pediatric systemic lupus erythematosus10.3FAS, FASLG
8gonococcal bursitis10.3CD4, STAT1
9granulomatous gastritis10.3FAS, FASLG
10ocular hypertension10.3CD4, CD8A
11ethmoid sinus cancer10.3CD163, FASLG, MMP9
12arteriovenous malformation10.3CD4, CD8A
13actinobacillosis10.3CD4, CD8A
14meckel's diverticulitis10.3CD4, CD8A
15scrotum squamous cell carcinoma10.3CD4, CD8A
16spindle epithelial tumor with thymus-like differentiation tumor10.3MMP9, TIMP1
17acute cystitis10.2CD4, CD8A
18folliculitis10.2CD4, CD8A
19cd3gamma deficiency10.2CD4, CD8A
20malignant giant cell tumor10.2CD163, IL1B, MMP9
21vaccinia10.2CD4, CD8A
22esophagus carcinoma in situ10.2CD4, CD8A
23steatorrhea10.2CD4, CXCL10, TIMP1
24keratoconjunctivitis10.2CD4, CD8A
25intestinal disaccharidase deficiency10.2CD4, CD8A
26immunodeficiency 27b, mycobacteriosis, ad10.2IL1B, MMP9, TIMP1
27cecum adenoma10.2MMP9, MUC5AC, TIMP1
28penis basal cell carcinoma10.2CD4, CD8A
29intestinal variant cervical mucinous adenocarcinoma10.1IL1B, MMP9, TIMP1
30mononeuritis of lower limb10.1IL1B, MMP9, TIMP1
31lung hilum cancer10.1IL1B, MMP9, TIMP1
32chronic eosinophilic pneumonia10.1CD4, CD8A
33melorheostosis10.1IL1B, TIMP1
34palmoplantar keratosis10.1IL1B, MMP9, TIMP1
35gingivitis10.1IL1B, MMP9, TIMP1
36pediatric infratentorial ependymoma10.1CD207, CD4, CD8A
37chronic rhinitis10.1IL1B, MMP9, TIMP1
38echinococcosis10.1CD4, IL1B, TIMP1
39brown-vialetto-van laere syndrome10.1CD4, CD8A, MMP9
40psoriasis10.0CD4, CD8A
41lacrimal system cancer10.0CD4, CD8A, FAS
4212p12.1 microdeletion syndrome10.0FAS, FASLG, MUC5AC
43chronic conjunctivitis10.0CD4, CD8A, STAT1
44neurotic excoriation10.0CD4, CD8A
45sinusitis10.0FAS, FASLG, IL1B
46asbestosis10.0FAS, FASLG, IL1B
47white piedra10.0CD4, CD8A, CXCL10
48alcoholic psychosis10.0CD4, GJB6
49thoracic aortic aneurysm10.0CD4, IL1B, MUC5AC
50blind hypotensive eye9.9CD4, IL1B, MUC5AC

Graphical network of the top 20 diseases related to Central Nervous System Tuberculosis:



Diseases related to central nervous system tuberculosis

Symptoms for Central Nervous System Tuberculosis

About this section

UMLS symptoms related to Central Nervous System Tuberculosis:


mass in head or neck

Drugs & Therapeutics for Central Nervous System Tuberculosis

About this section

Drugs for Central Nervous System Tuberculosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 172)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 2115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
2
Dexamethasoneapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2208450-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
 
Dexameth
Dexamethansone
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
3
Prednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 2115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
4
Aspirinapproved, vet_approvedPhase 4, Phase 2111250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
 
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
5AnalgesicsPhase 4, Phase 3, Phase 2, Phase 111287
6Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 117734
7ParasympatholyticsPhase 41050
8Tiotropium BromidePhase 4324136310-93-5
9Respiratory System AgentsPhase 4, Phase 34818
10Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 122776
11Cholinergic AntagonistsPhase 41658
12Analgesics, Non-NarcoticPhase 4, Phase 3, Phase 2, Phase 16260
13Anti-Asthmatic AgentsPhase 4, Phase 33369
14Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 3, Phase 2, Phase 14295
15Antirheumatic AgentsPhase 4, Phase 3, Phase 2, Phase 110627
16Cyclooxygenase InhibitorsPhase 4, Phase 3, Phase 2, Phase 12778
17Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 2, Phase 110355
18Autonomic AgentsPhase 4, Phase 3, Phase 29774
19BromidesPhase 4606
20Cholinergic AgentsPhase 43846
21Bronchodilator AgentsPhase 4, Phase 32856
22Prednisolone phosphatePhase 4, Phase 3, Phase 21153
23Prednisolone acetatePhase 4, Phase 3, Phase 21153
24Prednisolone hemisuccinatePhase 4, Phase 3, Phase 21153
25Protective AgentsPhase 4, Phase 3, Phase 27190
26HIV Protease InhibitorsPhase 4, Phase 3, Phase 2, Phase 15319
27Adrenergic AgentsPhase 4, Phase 35140
28Neuroprotective AgentsPhase 4, Phase 3, Phase 21672
29Dexamethasone acetatePhase 4, Phase 3, Phase 220841177-87-3
30Dexamethasone 21-phosphatePhase 4, Phase 3, Phase 22084
31BB 1101Phase 4, Phase 3, Phase 22084
32
protease inhibitorsPhase 4, Phase 3, Phase 2, Phase 15320
Synonyms:
 
protease inhibitors
33Dermatologic AgentsPhase 4, Phase 25674
34
FluticasonePhase 463090566-53-3, 80474-14-262924, 22833648
Synonyms:
90566-53-3
AC-456
AC1NSJZT
Asmatil
Axotide
BIDD:GT0819
Brethal
C07815
CHEMBL1201396
CID5311101
Cultivate
Cutivate
D07981
Flixonase
Flixonase Nasal Spray
Flixotide
Flixotide Disk
 
Flixotide Disks
Flixotide Inhaler
Flonase
Flovent
Flovent Diskus
Flovent Rotadisk
Fluinol
Flunase
Flusonal
Fluspiral
Fluticaps
Fluticaps (TN)
Fluticasone (INN)
Fluticasonpropionat Allen
Flutide
Flutivate
MolPort-006-666-449
S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate
fluticasone
35Fluticasone Propionate, Salmeterol Xinafoate Drug CombinationPhase 4201
36Anti-Allergic AgentsPhase 41490
37Adrenergic beta-AgonistsPhase 4, Phase 31640
38Methylprednisolone HemisuccinatePhase 4, Phase 3, Phase 21153
39Adrenergic beta-2 Receptor AgonistsPhase 4, Phase 3925
40glucocorticoidsPhase 4, Phase 3, Phase 24920
41Adrenergic AgonistsPhase 4, Phase 32877
42Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 25407
43Methylprednisolone acetatePhase 4, Phase 3, Phase 21153
44Hormone AntagonistsPhase 4, Phase 3, Phase 212778
45AntiemeticsPhase 4, Phase 3, Phase 23888
46Gastrointestinal AgentsPhase 4, Phase 3, Phase 28109
47HormonesPhase 4, Phase 3, Phase 213979
48Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 212767
49
Salmeterol xinafoatePhase 435094749-08-356801
Synonyms:
(+-)-4-Hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol 1-hydroxy-2-naphthoate (salt)
(+/-) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate
1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-, 1-hydroxy-2-naphthalenecarboxylate (salt)
1-hydroxynaphthalene-2-carboxylic acid
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
89365-50-4 (Parent)
94749-08-3
AC1L1LPS
Arial
Asmerole
Beglan
Betamican
Bio-0096
C25H37NO4.C11H8O3
CHEMBL1082607
CID56801
D00687
Dilamax
EU-0101100
GR 33343 G
GR 33343X xinafoate
 
GR-33343 G
Inaspir
LS-94516
MLS001332577
MLS001332578
MolPort-003-850-218
NCGC00094372-01
NCGC00094372-02
NCGC00094372-03
NCGC00094372-04
S5068_SIGMA
SMR000875207
Salmetedur
Salmeterol 1-hydroxy-2-naphthoate
Salmeterol xinafoate (JAN/USAN)
Salmeterol xinafoate [USAN]
Serevent (TN)
Serevent Inhaler and Disks
Serevent diskus
UNII-6EW8Q962A5
Ultrabeta
salmeterol xinafoate
50AntipyreticsPhase 4, Phase 21534

Interventional clinical trials:

(show all 40)
idNameStatusNCT IDPhase
1Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in KoreaCompletedNCT00864812Phase 4
2Investigation of the Effect of Systemic Steroids on Treatment and Prevention of Recurrent Tracheal Stenosis in Postoperative PatientsEnrolling by invitationNCT02855502Phase 4
3The Relationships Between Gene Polymorphisms of LTA4H and Dexamethasone Treatment for Tuberculous MeningitisNot yet recruitingNCT02588196Phase 4
4Benign Acute Pericarditis: Brief Versus Longer Treatment Using AspirinTerminatedNCT00946907Phase 4
5TB-IRIS NSAID Cox-2 Inhibitor Prevention TrialUnknown statusNCT02060006Phase 3
6Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRCCompletedNCT01589289Phase 3
7A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible BronchoscopyCompletedNCT01955824Phase 2, Phase 3
8Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone TherapyCompletedNCT00294658Phase 3
9A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and VomitingCompletedNCT02517021Phase 3
10Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VIRecruitingNCT02437253Phase 2, Phase 3
11High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding StudyActive, not recruitingNCT02169882Phase 2, Phase 3
12A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR)TerminatedNCT01351792Phase 3
13Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment TrialWithdrawnNCT01442428Phase 2, Phase 3
14Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled StudyWithdrawnNCT01614977Phase 3
15Metronidazole for Pulmonary Tuberculosis (South Korea)CompletedNCT00425113Phase 2
16Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous PreparationCompletedNCT01802502Phase 2
17Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability StudyCompletedNCT01158755Phase 2
18Augmentation of Psychotherapy With D-Cycloserine in AgoraphobiaCompletedNCT01928823Phase 2
19Infliximab (Remicade ) to Treat Dermatomyositis and PolymyositisCompletedNCT00033891Phase 2
20Progression of HIV-Disease Under Low Dose CorticosteroidsCompletedNCT01299948Phase 2
21Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and VomitingCompletedNCT00503386Phase 2
22A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous MeningitisActive, not recruitingNCT02237365Phase 2
23Pilot Study to Estimate the Potential Efficacy and Safety of Using Adjunctive Ibuprofen for the Treatment of XDR TuberculosisEnrolling by invitationNCT02781909Phase 2
24Optimizing Treatment to Improve TBM Outcomes in ChildrenNot yet recruitingNCT02958709Phase 1, Phase 2
25Interaction of Buprenorphine With HIV Medications and Tuberculosis MedicationsCompletedNCT00877591Phase 1
26Evaluation of the Pharmacokinetic Interaction Between PA-824 and MidazolamCompletedNCT01768273Phase 1
27Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy VolunteersCompletedNCT01162486Phase 1
28Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis PandemicRecruitingNCT02503839Phase 1
29Cycloserine in the Treatment of Sleep ApneaTerminatedNCT02735694Phase 1
30Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous MeningitisUnknown statusNCT00433719
31Local Anesthesia and Tuberculin Skin Test in Infants and ChildrenUnknown statusNCT00309673
32Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in SchizophreniaUnknown statusNCT00717509
33Tiotropium in Patients With Tuberculosis (TB) Destroyed LungUnknown statusNCT01365702
34Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive DexamethasoneCompletedNCT01317654
35Rijavithi Viral and Mycobacterium PCR Arrays in CNS Infection StudyCompletedNCT00807378
36Diagnosis of Tuberculous Meningitis by ESAT-6 in CSFCompletedNCT01371916
37Effectiveness of Alcohol Interventions Among Tuberculosis (TB) Patients in Tomsk Oblast, RussiaCompletedNCT00675961
38Levofloxacin in Bacterial RhinosinussitisCompletedNCT02712502
39E-Nose: Diagnostic Tool for Pleural TBActive, not recruitingNCT02765087
40A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South AfricaNot yet recruitingNCT02519803

Search NIH Clinical Center for Central Nervous System Tuberculosis


Cochrane evidence based reviews: tuberculoma, intracranial

Genetic Tests for Central Nervous System Tuberculosis

About this section

Anatomical Context for Central Nervous System Tuberculosis

About this section

MalaCards organs/tissues related to Central Nervous System Tuberculosis:

35
Brain, Spinal cord, Testes, Skin, Lung, T cells, Monocytes

FMA organs/tissues related to Central Nervous System Tuberculosis:

17
Brain or

Animal Models for Central Nervous System Tuberculosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Central Nervous System Tuberculosis:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020069.0FAS, FASLG, IL1B, MMP9, STAT1, TIMP1
2MP:00053858.4CXCL10, FAS, FASLG, GJB6, IL1B, MMP9
3MP:00107718.2CD4, CD8A, FAS, FASLG, GJB6, IL1B
4MP:00036317.3ARG1, CD4, CD8A, CXCL10, FAS, FASLG
5MP:00107687.2ARG1, CD4, CD8A, CXCL10, FAS, FASLG
6MP:00053907.2ANXA5, FAS, FASLG, IL1B, MMP9, POU3F3
7MP:00053767.1ARG1, CD4, CXCL10, FAS, FASLG, GJB6
8MP:00053976.4ANXA5, ARG1, CD207, CD4, CD8A, CXCL10
9MP:00053875.6ANXA5, ARG1, CD207, CD4, CD8A, CXCL10

Publications for Central Nervous System Tuberculosis

About this section

Articles related to Central Nervous System Tuberculosis:

(show top 50)    (show all 78)
idTitleAuthorsYear
1
Tuberculous ventriculitis: A rare complication of central nervous system tuberculosis. (27242238)
2016
2
Central nervous system tuberculosis: an imaging-focused review of a reemerging disease. (25653877)
2015
3
Immune reconstitution inflammatory syndrome in central nervous system tuberculosis. (27451593)
2015
4
Central nervous system tuberculosis reviewed. (26338350)
2015
5
Microglia are crucial regulators of neuro-immunity during central nervous system tuberculosis. (26041993)
2015
6
Risk Factors for Central Nervous System Tuberculosis. (26438712)
2015
7
Characteristics of central nervous system tuberculosis in a low-incidence country: a series of 20 cases and a review of the literature. (24451103)
2014
8
Central nervous system tuberculosis. (24887691)
2014
9
HIV-associated central nervous system tuberculosis. (24715493)
2014
10
Cerebral infarction and tuberculoma in central nervous system tuberculosis: frequency and prognostic implications. (24623792)
2014
11
Central nervous system tuberculosis. (25241567)
2014
12
A rare case of central nervous system tuberculosis. (25478256)
2014
13
Central nervous system tuberculosis presenting as branch retinal vein occlusion. (22738141)
2013
14
Central Nervous System Tuberculosis: Challenges and Advances in Diagnosis and Treatment. (24122343)
2013
15
Multi-drug-resistant central nervous system tuberculosis. (22626692)
2012
16
Central nervous system tuberculosis: mimicking neuropsychiatric systemic lupus erythematosus. (22367698)
2012
17
Role of Mycobacterium tuberculosis pknD in the pathogenesis of central nervous system tuberculosis. (22243650)
2012
18
Central nervous system tuberculosis: pathophysiology and imaging findings. (23122262)
2012
19
A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis. (22647865)
2012
20
Central nervous system tuberculosis: a forgotten diagnosis. (22735252)
2012
21
Hypopituitarism as unusual sequelae to central nervous system tuberculosis. (22029037)
2011
22
Central nervous system tuberculosis. (21572867)
2011
23
Lymphocyte apoptosis in children with central nervous system tuberculosis: a case control study. (22111973)
2011
24
Central nervous system tuberculosis. (22032500)
2011
25
Management of central nervous system tuberculosis in children: light and shade. (21222370)
2010
26
Central nervous system tuberculosis. (20944756)
2010
27
Central nervous system tuberculosis and adjuvant corticosteroid therapy. (19182749)
2009
28
Pathogenesis of central nervous system tuberculosis. (19275620)
2009
29
Magnetic resonance imaging in central nervous system tuberculosis. (19881100)
2009
30
Central nervous system tuberculosis subsequent to dural grafting. (18973080)
2008
31
Diagnosis of central nervous system tuberculosis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. (18632925)
2008
32
Diagnostic challenges of central nervous system tuberculosis. (18760024)
2008
33
IFNgamma synergizes with IL-1beta to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis. (17158965)
2007
34
Mortality associated with central nervous system tuberculosis. (17920686)
2007
35
Central nervous system tuberculosis and paradoxical response. (16634237)
2006
36
Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis. (16586367)
2006
37
Early detection of central nervous system tuberculosis with the gen-probe nucleic Acid amplification assay: utility in an inner city hospital. (12115103)
2002
38
Central nervous system tuberculosis: imaging manifestations. (10775956)
2000
39
Central nervous system tuberculosis. (10517926)
1999
40
Central nervous system tuberculosis--the paradox of the host immune response. (9515661)
1998
41
Central nervous system tuberculosis in children: a review of 214 cases. (9794979)
1998
42
Central nervous system tuberculosis after resolution of miliary tuberculosis. (9655548)
1998
43
Presumed ocular and central nervous system tuberculosis in a patient with the acquired immunodeficiency syndrome. (8623897)
1996
44
Paradoxical progression of tuberculous lesions during chemotherapy of central nervous system tuberculosis. Report of four cases. (7616286)
1995
45
MR imaging of central nervous system tuberculosis. (7610244)
1995
46
Central nervous system tuberculosis in Australia: a report of 22 cases. (8479355)
1993
47
Central nervous system tuberculosis in infants and children. (8299041)
1993
48
Central nervous system tuberculosis. (1622527)
1992
49
Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. (3729203)
1986
50
Central nervous system tuberculosis: a persistent disease. (5312859)
1971

Variations for Central Nervous System Tuberculosis

About this section

Expression for genes affiliated with Central Nervous System Tuberculosis

About this section
Search GEO for disease gene expression data for Central Nervous System Tuberculosis.

Pathways for genes affiliated with Central Nervous System Tuberculosis

About this section

Pathways related to Central Nervous System Tuberculosis according to GeneCards Suite gene sharing:

(show all 23)
idSuper pathwaysScoreTop Affiliating Genes
19.8STAT1, TIMP1
29.6CD4, MMP9, STAT1
3
Show member pathways
9.3CD4, IL1B, STAT1
4
Show member pathways
9.3CD4, IL1B, STAT1
59.3CD163, CD4, CD8A
69.2CXCL10, IL1B, STAT1
79.2FAS, FASLG, IL1B
89.1ARG1, CXCL10, IL1B, MMP9
99.0CD4, CD8A, IL1B
109.0CD4, CD8A, IL1B
119.0CXCL10, FAS, IL1B, MMP9
12
Show member pathways
8.9CD4, IL1B, STAT1, TIMP1
13
Show member pathways
8.7CD4, CD8A, FAS, IL1B
14
Show member pathways
8.5CD4, FAS, FASLG, IL1B, STAT1
158.5CD163, CD207, CD4, CD8A, IL1B
16
Show member pathways
8.4CXCL10, FAS, FASLG, IL1B, STAT1
17
Show member pathways
8.4CXCL10, FAS, FASLG, IL1B, STAT1
18
Show member pathways
8.2CD4, CD8A, FASLG, IL1B, STAT1
19
Show member pathways
8.2CXCL10, FAS, FASLG, IL1B, MMP9, STAT1
20
Show member pathways
8.1CD4, CXCL10, FAS, FASLG, IL1B, TIMP1
21
Show member pathways
7.9CD4, CD8A, FAS, FASLG, IL1B, STAT1
22
Show member pathways
7.7CD4, CXCL10, FAS, FASLG, IL1B, STAT1
237.5CD4, CD8A, CXCL10, FAS, FASLG, IL1B

GO Terms for genes affiliated with Central Nervous System Tuberculosis

About this section

Cellular components related to Central Nervous System Tuberculosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1T cell receptor complexGO:004210110.2CD4, CD8A
2external side of plasma membraneGO:00098977.7ANXA5, CD4, CD8A, CXCL10, FAS, FASLG
3extracellular spaceGO:00056157.4ARG1, CXCL10, FAS, FASLG, IL1B, MMP9
4extracellular regionGO:00055767.0CD163, CD8A, CXCL10, FAS, FASLG, IL1B

Biological processes related to Central Nervous System Tuberculosis according to GeneCards Suite gene sharing:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1inflammatory cell apoptotic processGO:000692510.5FAS, FASLG
2necroptotic signaling pathwayGO:009752710.4FAS, FASLG
3response to growth factorGO:007084810.4FAS, FASLG
4activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathwayGO:009729610.4FAS, FASLG
5regulation of extrinsic apoptotic signaling pathway via death domain receptorsGO:190204110.3FAS, FASLG
6positive regulation of interleukin-2 biosynthetic processGO:004508610.3CD4, IL1B
7positive regulation of calcium-mediated signalingGO:005085010.2CD4, CD8A
8cellular response to glucose stimulusGO:00713339.9FAS, GJB6, IL1B
9response to vitamin DGO:00332809.8CD4, CXCL10, IL1B
10negative regulation of angiogenesisGO:00165259.8CXCL10, FASLG, STAT1
11defense response to virusGO:00516079.3CD207, CD8A, CXCL10, STAT1
12response to peptide hormoneGO:00434349.2ARG1, FAS, IL1B, STAT1, TIMP1
13agingGO:00075688.9ARG1, FAS, GJB6, IL1B, TIMP1
14apoptotic processGO:00069158.8FAS, FASLG, GJB6, IL1B, STAT1
15negative regulation of apoptotic processGO:00430668.8ANXA5, FAS, MMP9, POU3F3, TIMP1
16response to lipopolysaccharideGO:00324968.7ARG1, CXCL10, FAS, FASLG, GJB6, IL1B
17immune responseGO:00069558.7CD4, CD8A, CXCL10, FAS, FASLG
18positive regulation of apoptotic processGO:00430658.4ANXA5, FAS, FASLG, IL1B, MMP9
19positive regulation of cell proliferationGO:00082848.4CXCL10, FASLG, POU3F3, STAT1, TIMP1
20signal transductionGO:00071657.6ANXA5, CD4, CXCL10, FAS, FASLG, IL1B

Sources for Central Nervous System Tuberculosis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet